Notice No.   20200213-16   Notice Date   13 Feb 2020
Category   Company related   Segment   SME
Subject   Listing of Equity Shares of Chandra Bhagat Pharma Limited
Attachments   Annexure II.pdf ; Annexure I.pdf ;

Trading Members of the Exchange are hereby informed that effective from Friday, February 14, 2020, the Equity Shares of Chandra Bhagat Pharma Limited shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days:

Name of the company

Chandra Bhagat Pharma Limited

Registered Office:

323-F Bhagat Bhuvan,

Dr Ambedkar Road

Matunga (East), Mumbai 400019

Tel :91 22 2414 6154



No. of Securities

7545056 Equity Shares of Rs.10/- each fully paid up

Distinctive Number range

1 To 7545056

Scrip ID on BOLT System


Abbreviated Name on BOLT System


Scrip Code




Market Lot


Issue Price for the current Public issue

Rs. 51/- per share (Face Value of Rs. 10/- and premium of Rs. 41/-)

Date of Allotment in the public issue:

February 11, 2020

Pari Pasu


Financial Year


Lock in detail

As per Annexure I

Shareholding Pattern

As per Annexure II


a)      Trading Members may note that as per the guidelines issued by SEBI dated 16th February 2000, securities of the Company will only be traded in Dematerialized form. Trades effected in this scrip will be in minimum market lot (i.e. 2000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of at least one month.

b)      Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Friday, February 14, 2020 . For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.

c)      The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.

d)      The Market Maker to the issue as mentioned in the prospectus is given below:

Beeline Broking Limited

Office No. 1 To 3, Vishwa Complex,

First Floor Opp. Jain Derasar, Navrangpura Ahmedabad - 380009.

Contact Person: Mr. Vanesh Panchal;

Tel: +91 – 079 – 6817 4040;



SEBI Registration No.: INZ000000638


e)      The Registrar to the issue as mentioned in the prospectus is given below

Link Intime India Private Limited

C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg,

Vikhroli (West), Mumbai – 400 083

Tel. Number: +91 22 4918 6200

Email Id:

Investors Grievance Id:


Contact Person: Ms. Shanti Goapalkrishnan

SEBI Registration Number: INR000004058


f)       In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:

a)      At the company:

Payal Bansal

Company Secretary and Compliance Officer


323-F Bhagat Bhuvan,

Dr Ambedkar Road

Matunga (East), Mumbai 400019

Tel :91 22 2414 6154



b) At the Exchange:

Rupal Khandelwal

Senior Manager

Tel.: (91) 022 2272 8262



Rupal Khandelwal

Senior Manager

Thursday, February 13,2020